Mirabegron, a breakthrough in overactive bladder syndrome?
<p><strong>Objective:</strong> Overactive bladder syndrome is a condition with high prevalence, which has a negative impact on patients’ quality of life. A drug with a novel mechanism of action has been recently approved: mirabegron. The objective of this study is to review the...
Main Authors: | Almudena Maestro Nombela, María José Almodóvar Carretón, Virginia Saavedra Quirós, Carlos Barreda Velázquez, Lucía Jamart Sánchez |
---|---|
Format: | Article |
Language: | English |
Published: |
Grupo Aula Médica
2017-05-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/10620.pdf |
Similar Items
-
Perspectives on mirabegron in the treatment of overactive bladder syndrome: A new beta-3 adrenoceptor agonist
by: Chia-Hao Kuei, et al.
Published: (2015-03-01) -
Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms
by: Tomasz Aleksiewicz, et al.
Published: (2018-08-01) -
Mirabegron: A first-in-class beta-3 agonist for overactive bladder
by: Suruchi Aditya, et al.
Published: (2015-01-01) -
THE EFFICACY COMPARISON OF MIRABEGRON AS A MONOTHERAPY VERSUS ITS COMBINATION WITH SOLIFENACIN IN OVERACTIVE BLADDER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
by: Hasan Madani, et al.
Published: (2021-07-01) -
The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
by: Marilena Gubbiotti, et al.
Published: (2019-01-01)